🇺🇸 FDA
Pipeline program

A clinical trial of MK-6916 in healthy participants (MK-6916-010)

MK-6916-010

Phase 1 other active

Quick answer

A clinical trial of MK-6916 in healthy participants (MK-6916-010) for Acute and Chronic pain is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Acute and Chronic pain
Phase
Phase 1
Modality
other
Status
active

Clinical trials